Login
$SNDX
$9.13 -$0.32 (3.39%) Live

Company Executives

Officer Age In this role 2025 pay Source
Michael A. Metzger Also a director
Chief Executive Officer
Title from the Form 4 dated Jul 8, 2026
Not stated Not stated $7,089,213
Aaron A. Ondrey
Chief Financial Officer
Title from the Form 8-K dated Nov 9, 2026
Not stated Not stated Not reported
Luke J. Albrecht
General Counsel and Secretary
47 Not stated $2,331,617
Nick Botwood
Head of Research and Development, Chief Medical Officer
58 Since 2025
1 year
$2,879,099
Steve Closter
Chief Commercial Officer
57 Since 2024
2 years
$2,125,887
Nicholas A.J. Botwood
Head of R&D, CMO
Title from the Form 4 dated Jun 11, 2026
Not stated Not stated Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
7
serving now
Independent
6 of 7
stated in the proxy
Average tenure
8.3 years
from year joined
CEO also chairs the board
No
Dennis G. Podlesak
Director Age On board Independent Other public boards 2025 pay Source
Dennis G. Podlesak
68 2008
18 years
Independent None stated $947,000
Michael A. Metzger
Not stated 2019
7 years
Not independent Pyxis Oncology Paid as CEO
Pierre Legault
Not stated 2017
9 years
Independent None stated $503,750
Martin H. Huber, M.D.
66 2021
5 years
Independent None stated $433,750
Jennifer Jarrett
55 2018
8 years
Independent Damora, Sagimet Biosciences, Zura Bio $433,750
Keith A. Katkin
54 2017
9 years
Independent Eledon Pharmaceuticals, Inc., Emergent BioSolutions, Inc. $511,250
Aleksandra Rizo, M.D., Ph.D.
51 2024
2 years
Independent None stated $426,250

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 30, 2026 states there were none.

Read it in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support